Evidence that the risks of misoprostol outweigh its benefits in stable cyclosporine-treated renal allograft recipients

Transplantation. 1992 Sep;54(3):565-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cyclosporine / therapeutic use*
  • Female
  • Gastrointestinal Diseases / chemically induced
  • Graft Survival / drug effects
  • Humans
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Misoprostol / adverse effects*
  • Risk Factors
  • Transplantation, Homologous

Substances

  • Misoprostol
  • Cyclosporine